Pfizer agrees to pay $345 mln to resolve EpiPen pricing lawsuit
July 15 (Reuters) - Pfizer Inc (PFE.N) has agreed to pay $ 345 million to resolve claims from consumers alleging that they were exposed to anti-competitive practices by the drug maker and the company that owns the Emergency medication Mylan…